These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 43218)
1. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of propranolol to 4'-hydroxypropranolol in the rat and in man. Nelson WL; Powell ML Drug Metab Dispos; 1979; 7(6):351-5. PubMed ID: 43218 [TBL] [Abstract][Full Text] [Related]
2. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man. Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920 [TBL] [Abstract][Full Text] [Related]
3. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog. Moustafa MA; Claesen M; Adline J; Vandervorst D; Poupaert JH Drug Metab Dispos; 1983; 11(6):574-80. PubMed ID: 6140142 [TBL] [Abstract][Full Text] [Related]
4. N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects. Nelson WL; Bartels MJ Drug Metab Dispos; 1984; 12(3):345-52. PubMed ID: 6145562 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)lactic acid as a metabolite of propranolol in the rat, in man, and in the rat liver 9000 g supernatant fraction. Talaat RE; Nelson WL Drug Metab Dispos; 1986; 14(2):202-7. PubMed ID: 2870895 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of beta-adrenergic antagonists. Evidence for an arene oxide-NIH shift pathway in the aromatic hydroxylation of oxprenolol. Nelson WL; Burke TR J Med Chem; 1979 Sep; 22(9):1088-92. PubMed ID: 490554 [TBL] [Abstract][Full Text] [Related]
7. Glucuronidation of propranolol and 4'-hydroxypropranolol. Substrate specificity and stereoselectivity of rat liver microsomal glucuronyltransferases. Thompson JA; Hull JE; Norris KJ Drug Metab Dispos; 1981; 9(5):466-71. PubMed ID: 6117447 [TBL] [Abstract][Full Text] [Related]
8. Regioisomeric aromatic dihydroxylation of propranolol. Use of monohydroxylated intermediates for structural assignments of the metabolites formed in vitro. Talaat RE; Nelson WL Drug Metab Dispos; 1988; 16(2):207-11. PubMed ID: 2898334 [TBL] [Abstract][Full Text] [Related]
9. Aromatic hydroxylation of oxprenolol. Quantitation and stereoselectivity in the formation of 4'- and 5-hydroxyoxprenolol in vivo in the rat. Burke TR; Howald WN; Nelson WL Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):399-412. PubMed ID: 7403656 [TBL] [Abstract][Full Text] [Related]
10. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition. Marathe PH; Shen DD; Nelson WL Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280 [TBL] [Abstract][Full Text] [Related]
11. Pathways of propranolol metabolism. Use of the stable isotope twin-ion GC-MS technique to examine the conversion of propranolol to propranolol-diol by 9000g rat liver supernatant. Nelson WL; Burke TR Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):77-85. PubMed ID: 567368 [TBL] [Abstract][Full Text] [Related]
12. New ring-hydroxylated metabolites of propranolol: species differences and stereospecific 7-hydroxylation. Walle T; Oatis JE; Walle UK; Knapp DR Drug Metab Dispos; 1982; 10(2):122-7. PubMed ID: 6124396 [TBL] [Abstract][Full Text] [Related]
13. Chemical aspects of propranolol metabolism. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)propane-1,2-diol as a metabolite of propranolol in the dog, in man and in the rat liver 9000g supernatant fraction. Gupte SM; Bartels MJ; Kerr BM; Laganiere S; Silber BM; Nelson WL Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):235-44. PubMed ID: 6658188 [TBL] [Abstract][Full Text] [Related]
14. The pathways of propranolol metabolism in dog and rat liver 10,000g supernatant fractions. Vu VT; Abramson FP Drug Metab Dispos; 1980; 8(5):300-4. PubMed ID: 6107225 [TBL] [Abstract][Full Text] [Related]
15. Comparative study on the para-metabolic oxidation of phenytoin and decadeuteriophenytoin. Moustafa MA; el-Emam AA; Subbagh HI; el-Din MK Arzneimittelforschung; 1990 Oct; 40(10):1076-8. PubMed ID: 2291743 [TBL] [Abstract][Full Text] [Related]
16. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes. de Visser SP; Shaik S J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816 [TBL] [Abstract][Full Text] [Related]
17. Quantitative metabolic fate of propranolol in the dog, rat, and hamster using radiotracer, high performance liquid chromatography, and gas chromatography-mass spectrometry techniques. Bargar EM; Walle UK; Bai SA; Walle T Drug Metab Dispos; 1983; 11(3):266-72. PubMed ID: 6135586 [TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol. Narimatsu S; Kobayashi N; Asaoka K; Masubuchi Y; Horie T; Hosokawa M; Ishikawa T; Ohmori S; Kitada M; Miyano J; Kataoka H; Yamamoto S Chirality; 2001; 13(3):140-7. PubMed ID: 11270323 [TBL] [Abstract][Full Text] [Related]
19. Isomeric ring hydroxylated metabolites of propranolol in rats, man and dogs. Walle T; Morrison JI; Tindell GL Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):1-10. PubMed ID: 4438819 [No Abstract] [Full Text] [Related]
20. Stereoselective oxidative metabolism of propranolol in the microsomal fraction from rat and human liver. Use of deuterium labeling and pseudoracemic mixtures. Nelson WL; Shetty HU Drug Metab Dispos; 1986; 14(4):506-8. PubMed ID: 2874001 [No Abstract] [Full Text] [Related] [Next] [New Search]